United States (US) Lumasiran Market (2025-2031) | Segmentation, Forecast, Analysis, Trends, Competitive Landscape, Companies, Value, Growth, Industry, Size & Revenue, Outlook, Share

Name: United States (US) Lumasiran Market (2025-2031) | Segmentation & Forecast
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy
Keywords: Lumasiran Market, United States (US) Lumasiran Market, United States (US) Lumasiran Market Revenues, United States (US) Lumasiran Market Share, United States (US) Lumasiran Market Size, United States (US) Lumasiran Market Outlook, United States (US) Lumasiran Market Report, United States (US) Lumasiran Market Competition, United States (US) Lumasiran Market Overview, United States (US) Lumasiran Market Trends, United States (US) Lumasiran Market Forecast

Market Forecast By Drug Class (Miscellaneous Metabolic Agents, others), By Application (Primary Hyperoxaluria, Others), By Dosage form (Injection, Solution), By Route of Administration (Subcutaneous, Demographic, Adult, Pediatric), By End-Users (Clinics, Hospitals, Diagnostic center), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) And Competitive Landscape

Product Code: ETC9969566	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Bhawna Singh	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Lumasiran Market Outlook
Market Size of United States (US) Lumasiran Market, 2024
Forecast of United States (US) Lumasiran Market, 2031
Historical Data and Forecast of United States (US) Lumasiran Revenues & Volume for the Period 2021- 2031
United States (US) Lumasiran Market Trend Evolution
United States (US) Lumasiran Market Drivers and Challenges
United States (US) Lumasiran Price Trends
United States (US) Lumasiran Porter's Five Forces
United States (US) Lumasiran Industry Life Cycle
Historical Data and Forecast of United States (US) Lumasiran Market Revenues & Volume By Drug Class for the Period 2021- 2031
Historical Data and Forecast of United States (US) Lumasiran Market Revenues & Volume By Miscellaneous Metabolic Agents for the Period 2021- 2031
Historical Data and Forecast of United States (US) Lumasiran Market Revenues & Volume By others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Lumasiran Market Revenues & Volume By Application for the Period 2021- 2031
Historical Data and Forecast of United States (US) Lumasiran Market Revenues & Volume By Primary Hyperoxaluria for the Period 2021- 2031
Historical Data and Forecast of United States (US) Lumasiran Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Lumasiran Market Revenues & Volume By Dosage form for the Period 2021- 2031
Historical Data and Forecast of United States (US) Lumasiran Market Revenues & Volume By Injection for the Period 2021- 2031
Historical Data and Forecast of United States (US) Lumasiran Market Revenues & Volume By Solution for the Period 2021- 2031
Historical Data and Forecast of United States (US) Lumasiran Market Revenues & Volume By Route of Administration for the Period 2021- 2031
Historical Data and Forecast of United States (US) Lumasiran Market Revenues & Volume By Subcutaneous for the Period 2021- 2031
Historical Data and Forecast of United States (US) Lumasiran Market Revenues & Volume By Demographic for the Period 2021- 2031
Historical Data and Forecast of United States (US) Lumasiran Market Revenues & Volume By Adult for the Period 2021- 2031
Historical Data and Forecast of United States (US) Lumasiran Market Revenues & Volume By Pediatric for the Period 2021- 2031
Historical Data and Forecast of United States (US) Lumasiran Market Revenues & Volume By End-Users for the Period 2021- 2031
Historical Data and Forecast of United States (US) Lumasiran Market Revenues & Volume By Clinics for the Period 2021- 2031
Historical Data and Forecast of United States (US) Lumasiran Market Revenues & Volume By Hospitals for the Period 2021- 2031
Historical Data and Forecast of United States (US) Lumasiran Market Revenues & Volume By Diagnostic center for the Period 2021- 2031
Historical Data and Forecast of United States (US) Lumasiran Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
Historical Data and Forecast of United States (US) Lumasiran Market Revenues & Volume By Hospital Pharmacy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Lumasiran Market Revenues & Volume By Retail Pharmacy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Lumasiran Market Revenues & Volume By Online Pharmacy for the Period 2021- 2031
United States (US) Lumasiran Import Export Trade Statistics
Market Opportunity Assessment By Drug Class
Market Opportunity Assessment By Application
Market Opportunity Assessment By Dosage form
Market Opportunity Assessment By Route of Administration
Market Opportunity Assessment By End-Users
Market Opportunity Assessment By Distribution Channel
United States (US) Lumasiran Top Companies Market Share
United States (US) Lumasiran Competitive Benchmarking By Technical and Operational Parameters
United States (US) Lumasiran Company Profiles
United States (US) Lumasiran Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Lumasiran Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Lumasiran Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Lumasiran Market - Industry Life Cycle

3.4 United States (US) Lumasiran Market - Porter's Five Forces

3.5 United States (US) Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 United States (US) Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 United States (US) Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F

3.8 United States (US) Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.9 United States (US) Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F

3.10 United States (US) Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 United States (US) Lumasiran Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of rare diseases, such as primary hyperoxaluria type 1 (PH1), which can be treated by lumasiran.

4.2.2 Growing awareness and diagnosis rates of rare genetic disorders in the United States.

4.2.3 Favorable regulatory environment for orphan drug development and approval.

4.2.4 Technological advancements in biotechnology leading to improved drug development processes.

4.3 Market Restraints

4.3.1 High cost associated with lumasiran treatment may limit accessibility for patients.

4.3.2 Limited patient pool due to the rare nature of primary hyperoxaluria type 1.

4.3.3 Competition from alternative treatment options or emerging therapies for rare diseases.

4.3.4 Regulatory uncertainties or changes in reimbursement policies impacting market adoption.

5 United States (US) Lumasiran Market Trends

6 United States (US) Lumasiran Market, By Types

6.1 United States (US) Lumasiran Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 United States (US) Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 United States (US) Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F

6.1.4 United States (US) Lumasiran Market Revenues & Volume, By others, 2021- 2031F

6.2 United States (US) Lumasiran Market, By Application

6.2.1 Overview and Analysis

6.2.2 United States (US) Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F

6.2.3 United States (US) Lumasiran Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) Lumasiran Market, By Dosage form

6.3.1 Overview and Analysis

6.3.2 United States (US) Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F

6.3.3 United States (US) Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F

6.4 United States (US) Lumasiran Market, By Route of Administration

6.4.1 Overview and Analysis

6.4.2 United States (US) Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F

6.4.3 United States (US) Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F

6.4.4 United States (US) Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F

6.4.5 United States (US) Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F

6.5 United States (US) Lumasiran Market, By End-Users

6.5.1 Overview and Analysis

6.5.2 United States (US) Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F

6.5.3 United States (US) Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.4 United States (US) Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F

6.6 United States (US) Lumasiran Market, By Distribution Channel

6.6.1 Overview and Analysis

6.6.2 United States (US) Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.6.3 United States (US) Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.6.4 United States (US) Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

7 United States (US) Lumasiran Market Import-Export Trade Statistics

7.1 United States (US) Lumasiran Market Export to Major Countries

7.2 United States (US) Lumasiran Market Imports from Major Countries

8 United States (US) Lumasiran Market Key Performance Indicators

8.1 Patient enrollment in clinical trials for lumasiran.

8.2 Adoption rates of lumasiran in different regions of the United States.

8.3 Number of healthcare providers trained in prescribing and managing lumasiran treatment.

8.4 Patient adherence and persistence rates with lumasiran therapy.

8.5 Patient reported outcomes and quality of life improvements post-lumasiran treatment.

9 United States (US) Lumasiran Market - Opportunity Assessment

9.1 United States (US) Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 United States (US) Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 United States (US) Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F

9.4 United States (US) Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.5 United States (US) Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F

9.6 United States (US) Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 United States (US) Lumasiran Market - Competitive Landscape

10.1 United States (US) Lumasiran Market Revenue Share, By Companies, 2024

10.2 United States (US) Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Lumasiran Market

Estonia Lumasiran Market

Ethiopia Lumasiran Market

Fiji Lumasiran Market

Finland Lumasiran Market

Gabon Lumasiran Market

Global Lumasiran Market

Middle East Lumasiran Market

North America Lumasiran Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here